145 related articles for article (PubMed ID: 9152103)
1. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.
Ross BM; Hudson C; Erlich J; Warsh JJ; Kish SJ
Arch Gen Psychiatry; 1997 May; 54(5):487-94. PubMed ID: 9152103
[TBL] [Abstract][Full Text] [Related]
2. Increased serum phospholipase A2 activity in schizophrenia: a replication study.
Gattaz WF; Hübner CV; Nevalainen TJ; Thuren T; Kinnunen PK
Biol Psychiatry; 1990 Sep; 28(6):495-501. PubMed ID: 2223919
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.
Gattaz WF; Köllisch M; Thuren T; Virtanen JA; Kinnunen PK
Biol Psychiatry; 1987 Apr; 22(4):421-6. PubMed ID: 3567258
[TBL] [Abstract][Full Text] [Related]
4. Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.
Smesny S; Kinder D; Willhardt I; Rosburg T; Lasch J; Berger G; Sauer H
Biol Psychiatry; 2005 Feb; 57(4):399-405. PubMed ID: 15705356
[TBL] [Abstract][Full Text] [Related]
5. [Possible involvement of phospholipase A2 in the pathogenesis of schizophrenia].
Gattaz WF; Nevalainen TJ; Kinnunen PK
Fortschr Neurol Psychiatr; 1990 Apr; 58(4):148-53. PubMed ID: 2354835
[TBL] [Abstract][Full Text] [Related]
6. Serum calcium-independent phospholipase A2 activity in bipolar affective disorder.
Ross BM; Hughes B; Kish SJ; Warsh JJ
Bipolar Disord; 2006 Jun; 8(3):265-70. PubMed ID: 16696828
[TBL] [Abstract][Full Text] [Related]
7. [Accelerated breakdown of membrane phospholipids in schizophrenia--implications for the hypofrontality hypothesis].
Gattaz WF; Brunner J; Schmitt A; Maras A
Fortschr Neurol Psychiatr; 1994 Dec; 62(12):489-96. PubMed ID: 7835820
[TBL] [Abstract][Full Text] [Related]
8. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.
Ross BM; Turenne S; Moszczynska A; Warsh JJ; Kish SJ
Brain Res; 1999 Mar; 821(2):407-13. PubMed ID: 10064828
[TBL] [Abstract][Full Text] [Related]
9. Increased platelet phospholipase A2 activity in schizophrenia.
Gattaz WF; Schmitt A; Maras A
Schizophr Res; 1995 Jul; 16(1):1-6. PubMed ID: 7547640
[TBL] [Abstract][Full Text] [Related]
10. Elevated PLA2 activity in schizophrenics and other psychiatric patients.
Noponen M; Sanfilipo M; Samanich K; Ryer H; Ko G; Angrist B; Wolkin A; Duncan E; Rotrosen J
Biol Psychiatry; 1993 Nov; 34(9):641-9. PubMed ID: 8292693
[TBL] [Abstract][Full Text] [Related]
11. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia.
Barbosa NR; Junqueira RM; Vallada HP; Gattaz WF
Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):340-3. PubMed ID: 17629734
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase A2 activity in serum of neuroleptic-naive psychiatric inpatients.
Albers M; Meurer H; Märki F; Klotz J
Pharmacopsychiatry; 1993 May; 26(3):94-8. PubMed ID: 8415900
[TBL] [Abstract][Full Text] [Related]
13. Increased phospholipase A2 activity in schizophrenia with absent response to niacin.
Tavares H; Yacubian J; Talib LL; Barbosa NR; Gattaz WF
Schizophr Res; 2003 May; 61(1):1-6. PubMed ID: 12648730
[TBL] [Abstract][Full Text] [Related]
14. Serum phospholipases A2 in inflammatory diseases.
Nevalainen TJ
Clin Chem; 1993 Dec; 39(12):2453-9. PubMed ID: 8252715
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: possible implications for schizophrenia.
Brunner J; Gattaz WF
Eur Arch Psychiatry Clin Neurosci; 1995; 246(1):13-6. PubMed ID: 8773214
[TBL] [Abstract][Full Text] [Related]
16. Comparison of enzymatic and pharmacological activities of lysine-49 and aspartate-49 phospholipases A2 from Agkistrodon piscivorus piscivorus snake venom.
Dhillon DS; Condrea E; Maraganore JM; Heinrikson RL; Benjamin S; Rosenberg P
Biochem Pharmacol; 1987 May; 36(10):1723-30. PubMed ID: 3109429
[TBL] [Abstract][Full Text] [Related]
17. Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia.
Hudson C; Gotowiec A; Seeman M; Warsh J; Ross BM
Biol Psychiatry; 1999 Aug; 46(3):401-5. PubMed ID: 10435206
[TBL] [Abstract][Full Text] [Related]
18. Alterations of brain membranes in schizophrenia: impact of phospholipase A(2).
Schaeffer EL; Gattaz WF; Eckert GP
Curr Top Med Chem; 2012; 12(21):2314-23. PubMed ID: 23279172
[TBL] [Abstract][Full Text] [Related]
19. Reduced activities of phospholipases A2 in platelets of drug-naïve bipolar disorder patients.
Ikenaga EH; Talib LL; Ferreira AS; Machado-Vieira R; Forlenza OV; Gattaz WF
Bipolar Disord; 2015 Feb; 17(1):97-101. PubMed ID: 25041493
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
